Search results
Pharma’s $1 Trillion ‘Firepower’ Hangs Over Biotech Stocks in Limbo
Bloomberg via Yahoo Finance· 7 days ago(Bloomberg) -- A flurry of deals at the start of the year sparked optimism for a biotech stock...
Pharma awaits Fed relief with $1T in firepower to spend on biotech innovation: report
FierceBiotech· 7 days agoReserve delaying action on interest rates, biotechs still have grounds for continued cautious...
Kairos Pharma, Ltd. Prices IPO at $4.00 Per Share (KAPA)
ETF DAILY NEWS· 4 days agoKairos Pharma, Ltd. (KAPA) expects to raise $6 million in an IPO on the week of June 10th, IPO Scoop...
Biotech Blockbusters: 3 Pharma Stocks to Buy in June for Breakthrough Potential
InvestorPlace· 4 days agoOne of the most important sectors globally, it is hard to imagine life without biotech companies...
How is San Diego's biotech industry faring?
KPBS San Diego· 4 days agoSan Diego is a hub for biotech. S1: Then we'll tell you about the great innovations that have come out of San Diego and what's still to come. Much of the...
FSD Pharma Receives Institutional Review Board Approval to Study the Safety and Efficacy of...
Morningstar· 6 days agoTORONTO, ON / ACCESSWIRE / June 4, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma"), a biopharmaceutical company dedicated to building ...
European pharma regulation changes signal tumult and transformation
Pharmaceutical Technology via Yahoo Finance· 4 days agoThe additional requirements within the revised GPL, such as the one requiring orphan drugs to prove...
Cross This Bridge With a Potentially Big Upcoming Catalyst
TheStreet.com· 14 hours agoHere's why this midcap biotech name makes for a solid covered call trade. The company is $5 billion...
Stella Vnook on founding biotech companies and solid advice for women entering the field
BioPharma-Reporter· 5 days agoAs this week’s woman in science, we delve deeper into her impressive career, from where it began to...
UroGen Pharma appoints new Chief Commercial Officer By Investing.com
Investing.com· 7 days agoUroGen Pharma Ltd. (NASDAQ: URGN), a biotech company focused on urothelial and specialty cancers,...